Guru Ownership Trend
Guru Analysis for ARS Pharmaceuticals, Inc. (SPRY)
ARS Pharmaceuticals, Inc. (SPRY), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 1 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.83 M.
Top institutional holders include Chuck Royce.
Institutional sentiment is currently Bullish. This is evidenced by a $934,794 net inflow during the quarter.
Recent activity highlights Chuck Royce who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for ARS Pharmaceuticals, Inc. (SPRY)
Major holders include Chuck Royce ($2.41 M). According to the latest reported data, 1 tracked investment managers collectively hold approximately 207,051 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $934,794, with 1 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited SPRY. The total reported sell value was $1.48 M.
Yes, 1 managers opened new positions in SPRY, and 0 increased their existing holdings. The total reported buy value was $2.41 M.